Archer Investment Corporation’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.63M Sell
8,782
-4
-0% -$742 0.39% 53
2025
Q1
$1.84M Buy
8,786
+733
+9% +$154K 0.48% 47
2024
Q4
$1.43M Buy
8,053
+140
+2% +$24.9K 0.38% 54
2024
Q3
$1.56M Sell
7,913
-21
-0.3% -$4.15K 0.42% 53
2024
Q2
$1.36M Buy
7,934
+411
+5% +$70.5K 0.4% 57
2024
Q1
$1.37M Sell
7,523
-139
-2% -$25.3K 0.41% 56
2023
Q4
$1.19M Buy
7,662
+13
+0.2% +$2.02K 0.38% 58
2023
Q3
$1.14M Buy
7,649
+11
+0.1% +$1.64K 0.4% 61
2023
Q2
$1.03M Sell
7,638
-1,710
-18% -$230K 0.37% 65
2023
Q1
$1.41M Buy
9,348
+406
+5% +$61.2K 0.52% 43
2022
Q4
$1.45M Buy
8,942
+29
+0.3% +$4.69K 0.56% 37
2022
Q3
$1.2M Buy
8,913
+11
+0.1% +$1.48K 0.5% 45
2022
Q2
$1.36M Buy
8,902
+30
+0.3% +$4.6K 0.55% 37
2022
Q1
$1.45M Sell
8,872
-89
-1% -$14.6K 0.51% 42
2021
Q4
$1.21M Buy
8,961
+91
+1% +$12.3K 0.41% 62
2021
Q3
$957K Buy
8,870
+51
+0.6% +$5.5K 0.36% 68
2021
Q2
$993K Buy
8,819
+5
+0.1% +$563 0.39% 58
2021
Q1
$954K Hold
8,814
0.39% 58
2020
Q4
$944K Sell
8,814
-258
-3% -$27.6K 0.45% 51
2020
Q3
$795K Sell
9,072
-143
-2% -$12.5K 0.41% 55
2020
Q2
$905K Buy
9,215
+108
+1% +$10.6K 0.51% 43
2020
Q1
$694K Buy
9,107
+1,893
+26% +$144K 0.47% 46
2019
Q4
$638K Buy
7,214
+1,270
+21% +$112K 0.34% 66
2019
Q3
$450K Sell
5,944
-617,262
-99% -$46.7M 0.27% 92
2019
Q2
$450K Buy
623,206
+613,162
+6,105% +$443K 0.29% 81
2019
Q1
$820K Buy
10,044
+560
+6% +$45.7K 0.55% 40
2018
Q4
$874K Buy
+9,484
New +$874K 0.77% 33